Corporate
#NewAseBioMember | "AseBio is a strong association of public and private organizations inv...
Meet BioClonal, our new member. We talked to its with Paula Garfella Founder & CEO and Jessika Valero, CRO.
Sustainable Energy Solutions for Pharma and Biotech
ZETA is committed to making a positive contribution by delivering innovative and sustainable strategies that help our...
GENESIS Biomed kicks-off its new site at Valencia and holds its Annual Conference
GENESIS Biomed inaugurated its new site at Valencia last week at the BioHub VLC, as part of the GENESIS Biomed Annual...
#NewAseBioAlly | "AseBio is a gateway, a meeting point with and for companies, association...
Meet UNGRIA Patentes y Marcas, our new ally. We talked with Sergio Escorza Treviño, director del Departamento de...
ORYZON to provide corporate progress updates at several events in november
Oryzon’s CEO, Dr. Carlos Buesa, will attend the LSX Investival Showcase, to be held on November 13 at at Old...
ORYZON reports financial results and corporate updates for quarter ended September 30, 202...
Research and development (R&D) expenses of $3.8 and $12.2 million for the quarter and nine months ended September 30...
ORYZON to provide corporate progress updates at several events in October
Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in...
HOFFMANN EITLE Madrid & Barcelona celebrate their 10th anniversary in BIOSPAIN
As part of BIOSPAIN, from 26 to 28 September in Barcelona, HOFFMANN EITLE Madrid & Barcelona celebrated its tenth...
Oryzon announces completed patient recruitment in the PORTICO Phase IIb trial of vafidemst...
Multiple primary endpoints include reduction in agitation and aggression and overall disease improvement. Recent...